BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 35879556)

  • 1. Immune evasion and provocation by Mycobacterium tuberculosis.
    Chandra P; Grigsby SJ; Philips JA
    Nat Rev Microbiol; 2022 Dec; 20(12):750-766. PubMed ID: 35879556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages.
    Dabla A; Liang YC; Rajabalee N; Irwin C; Moonen CGJ; Willis JV; Berton S; Sun J
    mBio; 2022 Aug; 13(4):e0145622. PubMed ID: 35924849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
    Abreu R; Giri P; Quinn F
    Front Immunol; 2020; 11():1553. PubMed ID: 32849525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PE_PGRS30 of Mycobacterium tuberculosis mediates suppression of proinflammatory immune response in macrophages through its PGRS and PE domains.
    Chatrath S; Gupta VK; Dixit A; Garg LC
    Microbes Infect; 2016 Sep; 18(9):536-42. PubMed ID: 27129781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycobacterium tuberculosis virulence factors and its immune evasion mechanisms].
    Colakoğlu S
    Mikrobiyol Bul; 2004; 38(1-2):155-67. PubMed ID: 15293916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis Rv0431 expressed in Mycobacterium smegmatis, a potentially mannosylated protein, mediated the immune evasion of RAW 264.7 macrophages.
    Deng G; Zhang F; Yang S; Kang J; Sha S; Ma Y
    Microb Pathog; 2016 Nov; 100():285-292. PubMed ID: 27765619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.
    Ankley L; Thomas S; Olive AJ
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32094248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The
    Sharma T; Alam A; Ehtram A; Rani A; Grover S; Ehtesham NZ; Hasnain SE
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008950
    [No Abstract]   [Full Text] [Related]  

  • 9.
    Bo H; Moure UAE; Yang Y; Pan J; Li L; Wang M; Ke X; Cui H
    Front Cell Infect Microbiol; 2023; 13():1062963. PubMed ID: 36936766
    [No Abstract]   [Full Text] [Related]  

  • 10. ESAT-6 a Major Virulence Factor of
    Anes E; Pires D; Mandal M; Azevedo-Pereira JM
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371548
    [No Abstract]   [Full Text] [Related]  

  • 11. The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages.
    Sullivan JT; Young EF; McCann JR; Braunstein M
    Infect Immun; 2012 Mar; 80(3):996-1006. PubMed ID: 22215736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polyphosphate kinase gene ppk2 is required for Mycobacterium tuberculosis inorganic polyphosphate regulation and virulence.
    Chuang YM; Belchis DA; Karakousis PC
    mBio; 2013 May; 4(3):e00039-13. PubMed ID: 23695835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis.
    Goldberg MF; Saini NK; Porcelli SA
    Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host evasion and exploitation schemes of Mycobacterium tuberculosis.
    Cambier CJ; Falkow S; Ramakrishnan L
    Cell; 2014 Dec; 159(7):1497-509. PubMed ID: 25525872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage heterogeneity and plasticity in tuberculosis.
    Khan A; Singh VK; Hunter RL; Jagannath C
    J Leukoc Biol; 2019 Aug; 106(2):275-282. PubMed ID: 30938876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative Analysis of Human Macrophage Inflammatory Response Related to
    Bade P; Simonetti F; Sans S; Laboudie P; Kissane K; Chappat N; Lagrange S; Apparailly F; Roubert C; Duroux-Richard I
    Front Immunol; 2021; 12():668060. PubMed ID: 34276658
    [No Abstract]   [Full Text] [Related]  

  • 17. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stealth Strategies of
    Naeem MA; Ahmad W; Tyagi R; Akram Q; Younus M; Liu X
    Curr Issues Mol Biol; 2021; 41():597-616. PubMed ID: 33068079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis: Rewiring host cell signaling to promote infection.
    Stutz MD; Clark MP; Doerflinger M; Pellegrini M
    J Leukoc Biol; 2018 Feb; 103(2):259-268. PubMed ID: 29345343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of Mycobacterium tuberculosis and Toll-like receptor interaction: immune response or immune evasion?
    Saraav I; Singh S; Sharma S
    Immunol Cell Biol; 2014 Oct; 92(9):741-6. PubMed ID: 24983458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.